Genetic mutations in the human ISC genes impair this process and cause severe metabolic, neurological and hematological diseases, often with fatal outcomes, the most prevalent being Friedreich’s ataxia with mutations in the frataxin (FXN) gene9–13. The gene discussed is FXN; the disease is hematologic disorder.